Single-center Outcomes After Liver Transplantation With SARS-CoV-2-Positive Donors: An Argument for Increased Utilization.

Ashton A Connor Max W Adelman Constance M Mobley Mozhgon MoaddabAlexandra J ErhardtDavid E Hsu Elizabeth W BromboszMansi SanghviYee Lee Cheah Caroline J Simon Mark J Hobeika Ashish S Saharia David W Victor Sudha KodaliTamneet BasraEdward A Graviss Angelina M AlbertAhmed ElsaieyLinda W Moore Masayuki NigoAshley L DrewsKevin A Grimes César A Arias Xian Chang LiA Osama GaberR Mark Ghobrial

Published in: Transplantation direct (2024)

The utilization of liver grafts from COVID-19-positive donors was not associated with a decreased overall survival of recipients. There was no suggestion of viral transmission from donor to recipient. The results from this large single-center study suggest that COVID-19-positive donors may be used safely to expand the deceased donor pool.

Keyphrases

sars cov
kidney transplantation
coronavirus disease
respiratory syndrome coronavirus
type diabetes
metabolic syndrome
adipose tissue
weight loss
glycemic control